drugset / Trial / NCT07222254
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 in Healthy Japanese Participants
RandomizedSequentialQuadruple-blindTreatment
Summary
The purpose of the study is to evaluate the safety, tolerability and pharmacokinetics (PK) of single ascending doses of AZD0292 administered via intravenous (IV) infusion in healthy Japanese participants.
Timeline
- Start
- 2025-12-12
- Primary completion
- 2026-07-20
- Completion
- 2026-07-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD0292 | Monoclonal antibody | — | Intravenous |
Indications
No indication recorded.